Linezolid Vs. Vancomycin For Ventilator-Associated Pneumonia Caused By Methicillin-Resistant Staphylococcus Aureus

被引：0
|
作者：
Shorr, A. F.
Huang, D. B.
Wunderink, R. G.
Chastre, J. E.
Kollef, M.
Niederman, M. S.
机构：
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2011年 / 183卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3931
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia
    Andrew F Shorr
    Ying P Tabak
    Vikas Gupta
    RS Johannes
    Larry Z Liu
    Marin H Kollef
    Critical Care, 10
  • [22] Nebulized Bacteriophages for Prophylaxis of Experimental Ventilator-Associated Pneumonia Due to Methicillin-Resistant Staphylococcus aureus
    Prazak, Josef
    Valente, Luca
    Iten, Manuela
    Grandgirard, Denis
    Leib, Stephen L.
    Jakob, Stephan M.
    Haenggi, Matthias
    Que, Yok-Ai
    Cameron, David R.
    CRITICAL CARE MEDICINE, 2020, 48 (07) : 1042 - 1046
  • [23] Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia
    Shorr, Andrew F.
    Tabak, Ying P.
    Gupta, Vikas
    Johannes, R. S.
    Liu, Larry Z.
    Kollef, Marin H.
    CRITICAL CARE, 2006, 10 (03):
  • [24] Linezolid Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: Controversy Continues
    Masuta, Kana
    Oba, Yuichiro
    Iwata, Kentaro
    CLINICAL INFECTIOUS DISEASES, 2012, 55 (01) : 161 - 161
  • [25] Linezolid and vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia -: The subtleties of subgroup analyses
    Powers, JH
    Ross, DB
    Lin, D
    Soreth, J
    CHEST, 2004, 126 (01) : 314 - 315
  • [26] Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus
    Patel, Dipen A.
    Shorr, Andrew F.
    Chastre, Jean
    Niederman, Michael
    Simor, Andrew
    Stephens, Jennifer M.
    Charbonneau, Claudie
    Gao, Xin
    Nathwani, Dilip
    CRITICAL CARE, 2014, 18 (04)
  • [27] Linezolid versus vancomycin for methicillin-resistant Staphylococcus aureus infections
    Johnson, JR
    CLINICAL INFECTIOUS DISEASES, 2003, 36 (02) : 236 - 237
  • [28] Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus
    Dipen A Patel
    Andrew F Shorr
    Jean Chastre
    Michael Niederman
    Andrew Simor
    Jennifer M Stephens
    Claudie Charbonneau
    Xin Gao
    Dilip Nathwani
    Critical Care, 18
  • [29] Cost-Effectiveness of Linezolid vs Vancomycin in Suspected Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia in Germany
    De Cock, E.
    Krueger, W. A.
    Sorensen, S.
    Baker, T.
    Hardewig, J.
    Duttagupta, S.
    Mueller, E.
    Piecyk, A.
    Reisinger, E.
    Resch, A.
    INFECTION, 2009, 37 (02) : 123 - 132
  • [30] Cost-Effectiveness of Linezolid vs Vancomycin in Suspected Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia in Germany
    E. De Cock
    W. A. Krueger
    S. Sorensen
    T. Baker
    J. Hardewig
    S. Duttagupta
    E. Müller
    A. Piecyk
    E. Reisinger
    A. Resch
    Infection, 2009, 37
12345